Waystar Stock Gains Momentum as KeyBanc Forecasts 40% Upside

Key Facts

1KeyBanc initiated coverage on Waystar Holding with an Overweight rating and a $30 price target, suggesting a 40% upside.

2Waystar's Q1 fiscal 2026 earnings exceeded revenue forecasts, accompanied by a $200 million stock repurchase authorization.

In a move reflecting confidence in specialized fintech providers, KeyBanc has initiated coverage on Waystar Holding with an Overweight rating and a $30 price target, suggesting a potential 40% upside. This bullish stance follows Waystar's Q1 fiscal 2026 earnings, which exceeded revenue forecasts, and the authorization of a $200 million stock repurchase program. According to reports, KeyBanc identifies a valuation disconnect in the stock despite broader industry concerns regarding AI-driven disruptions.

This positive initiation comes as healthcare revenue cycle management (RCM) firms show resilient growth; for instance, peer company R1 RCM recently reported strong quarterly results driven by increased demand for payment automation. Per market data, Waystar's current valuation and its new buyback authorization align with a sector-wide trend of returning capital to shareholders amid stabilizing macroeconomic conditions and steady enterprise spending in healthcare IT.

Monitoring the price action, WAY closed at $21.43 (close July 1, 2026), having traded between a low of $20.66 and a high of $21.97 during the session. Investors should watch for upcoming catalysts, including the U.S. Initial Jobless Claims report on June 25, which may influence broader market sentiment toward mid-cap growth stocks in the healthcare technology space.